A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it ...
The FDA’s clearance marks a significant regulatory milestone for Jupiter, enabling the Company to begin enrollment in its exploratory Phase 2a trial designed to evaluate the safety and tolerability of ...
The outage that hit Amazon Web Services and took out vital services worldwide was the result of a single failure that ...
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it has ...
Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate ...
Following publication of BioProtect's pivotal randomized trial in the International Journal of Radiation Oncology, Biology, Physics (Red Journal) and presentation of the long-term quality-of-life ...
The current model of managing corporate identities is unprepared for a wave of AI agents gaining access to privileged resources.
Clinical Trials Arena on MSN
BridgeBio’s stock up as muscular dystrophy therapy meets Phase III endpoints
"BridgeBio’s stock up as muscular dystrophy therapy meets Phase III endpoints" was originally created and published by ...
Columbus Business First President & Publisher Nick Fortine speaks with experts from Trace3 and Cisco about how organizations ...
Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...
Supercharging recruitment processes has long been RPO’s calling card but with AI promising to transform recruitment, where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback